Cellshine has been selected for the Bio-Health Patent and Regulatory Consulting Support Program by the Korea Health Industry Development Institute (KHIDI).
JNPMEDI, a rising force in clinical and regulatory affairs, has been appointed as the consulting partner. Beyond regulatory consulting,
JNPMEDI is also exploring potential investment collaboration, positioning itself as a strategic partner in Cellshine’s growth journey.
Through this program, Cellshine will further refine its core technology patent strategy and strengthen its regulatory preparedness for both domestic and international markets.